15 5月 2019 by admin in UncategorizedComments resTORbio Reports First Quarter 2019 Financial Results and Corporate Update
08 5月 2019 by admin in UncategorizedComments NextCure Announces Pricing of Initial Public Offering of Common Stock
01 5月 2019 by admin in UncategorizedComments Syros Reports First Quarter 2019 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
02 4月 2019 by admin in UncategorizedComments Theodora Harold to be appointed new CEO at Crescendo Biologics
15 3月 2019 by admin in UncategorizedComments Crescendo Biologics wins in “Life Science Innovation” category at the Business Weekly Awards 2019
07 3月 2019 by admin in UncategorizedComments Syros Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Multiple Upcoming Clinical Milestones for Its First-in-Class Programs
04 3月 2019 by admin in UncategorizedComments NextCure and Yale Publish Nature Medicine Paper Detailing Novel Immunomedicine Target Siglec-15
28 2月 2019 by admin in UncategorizedComments Syros to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 7, 2019
12 2月 2019 by admin in UncategorizedComments NextCure Announces Formation of Scientific Advisory Board to Guide Development of its Portfolio of Immunomedicines
06 1月 2019 by admin in UncategorizedComments Syros Announces Strategic Priorities and Expected Milestones
